GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practice
Background: The interpretation of antibodies to glutamic acid decarboxylase 65 (GAD-Abs) in neurological practice is challenging. GAD-Abs are not considered directly pathogenic and immunotherapy guidelines are lacking. Methods: We undertook a single-center retrospective service evaluation of GAD-Abs...
Main Authors: | Brown, RL, Thomas-Black, G, Garcia-Moreno, H, Chou, M, Fleszar, Z, Zandi, MS, Chapman, M, Church, AJ, Hart, M, Giunti, P, Vincent, A, Lunn, MP |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Springer
2025
|
פריטים דומים
-
Stiff, twitchy or wobbly - Are GAD antibodies pathogenic?
מאת: Vincent, A
יצא לאור: (2008) -
Stiff, twitchy or wobbly: are GAD antibodies pathogenic?
מאת: Vincent, A
יצא לאור: (2008) -
GAD antibodies in stiff-person syndrome.
מאת: Chang, T, et al.
יצא לאור: (2004) -
Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss
מאת: Chang, T, et al.
יצא לאור: (2013) -
ANTI-GAD65, NMDAR AND VGKC ANTIBODIES DETECTED IN FIRST EPISODE PSYCHOSIS
מאת: Lennox, B, et al.
יצא לאור: (2009)